WE have come a long way with our national healthcare infrastructure since independence in 1957.
We reached another milestone at the start of this year when Malaysia became the seventh country included by a large multinational pharmaceutical company for a first in human (FIH) clinical trial, and the first within the Asia Pacific region, of a new, yet to be named drug being developed for use in rheumatology (The Star, Jan 4; online at bit.ly/3RN2zVZ).
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
